Cancer Pharmacology (part I) Flashcards
What are alkylating agents?
Highly reactive organic molecules which “alkylate” DNA by
interacting with nucleophilic groups in the DNA molecule. This disrupts normal DNA causing induction of
apoptosis.
What part of the cell cycle do alkylating agents target?
Alkylating agents are phase non-specific. Cells must be cycling to be killed, but the drugs are active at any point in the cycle
What type of response curve do alkylating agents have?
Alkylating agents have a linear response curve
- higher dose => more cells killed
What are common side effects of alkylating agents?
- Nausea
- Marrow suppression
- Mutagenesis
- Secondary carcinogenesis
What is mechlorethamine (nitrogen mustard)?
Mechlorethamine was the first chemotherapeutic agent
How is nitrogen mustard administered?
Nitrogen mustard is usually given via IV infusion but also topical to treat T-cell neoplasms
Why does mechlorethamine not require dose adjustment in renal or hepatic failure?
Mechlorethamine is rapidly regraded by NON-ENZYMATIC hydrolysis and therefore does not require dose adjustment in renal or hepatic failure
What are the major side effects of mechlorethamine?
- Nausea
- Vomiting
- Alopecia
- Myelosuppression
- Secondary cancers (especially leukemia, lymphoma, MDS)
What is Cyclophosphamide?
- A chemical derivative of mechlorethamine
- The most widely used of the alkylating agents – used in a variety of hematologic and solid tumors.
How is cyclophosphamide administered?
May be given either IV (used for higher doses) or orally.
How is cyclophosphamide activated and eliminated?
- Must be activated by the hepatic p450 system.
- Eliminated by hepatic metabolism (75%) of kidneys (25%).
What is a unique side effect of cyclophosphamide and how is it caused?
- Hemorrhagic cystitis.
- This is caused by the metabolite acrolein that is secreted in the urine.
- This can be prevented by aggressive hydration or (more commonly) MESNA (2-mercaptoethane sulphonate) that binds and inactivates acrolein in the urine.
What is cisplatin?
Cisplatin is a bifunctional alkylating agent that is a commonly used analogue
How does cisplatin work?
Cisplatin enters cells by passive diffusion then becomes ionized
- It binds to DNA to form interstrand and intrastrand cross links
- Cell cycle specific
What types of cancers is cisplatin used in?
- Lung
- Breast
- Ovarian
- Head and Neck cancers
What are the major side effects of cisplatin?
- Renal insufficiency
- Neuropathy
- Both are reversible
What is a “secondary” malignancy?
- Secondary malignancy are a side effect of drugs used to treat a primary or initial cancer
What is a common phenomena associated with secondary malignancy?
- Polycythemia vera
- Leukemia is also a side effect
Treatment of lymphoma leads to risk of what secondary condition?
- Treatment of lymphoma with intense therapy has lead to approximately 10% of patients being at risk of secondary leukemia and breast cancer
- Risk is greatly increased when alkylators and XRT are combined
What are the most common secondary malignancies?
- AML
- MDS
- These are usually highly resistant to any therapy
How does chemotherapy cause emesis?
- Enterochromaffin cells release serotonin in response to emetic chemotherapy agents
- When serotonin binds its receptor it acts on the vagus nerve leading to emesis/nausea
What is Ondansetron (Zofran)?
Ondansetron is a selective serotonin receptor blocking agent that is though to block 5HT stimulation of the vagus nerve
- It may also work by blocking CNS serotonin receptors
- HELPS TO PREVENT VOMITING AND NAUSEA
How is Ondansetron administered?
Ondansetron is given IV or po about 1/2 hour before chemo
What can Ondansetron be combined with for maximal benefit?
- Can be combined with steroids for maximal benefit
What is aprepitant?
Aprepitant, a nerokinin1 agonist that blocks substance P binding is a new antiemetic that can be combined with 5-HT inhibitors.
What are antimetabolite agents?
- Broadly antimetabolite agents inhibit the normal metabolic functions of cells
- Most antimetabolite drugs are targeted to DNA or RNA synthesis
- These agents commonly resemble normal metabolic intermediates